PharmacovigilanceOfficial
MHRA develops AdvanceGxP service to bring GxP advice into early innovation
🇬🇧 MHRA · Wed 18 Nov 2026
The UK regulator is building a free, regulator-led service to help developers of novel medicines technologies consider Good Practice requirements before key decisions are fixed; it is not yet open for applications.
The Medicines and Healthcare products Regulatory Agency (MHRA) has announced AdvanceGxP, a service in development that aims to help organisations working on novel medicines technologies consider Good Practice (GxP) requirements earlier. The agency says the goal is to reduce regulatory uncertainty while keeping regulatory and inspection decision-making independent.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (MHRA). AI-assisted; check the source before acting.
More Pharmacovigilance
All →
FDA early alert: Tablo power cord connections may overheat, Outset Medical updates instructions
🇺🇸 FDA MedWatch · Wed 18 Nov 2026
EMA publishes list of Union reference dates and PSUR submission frequencies
🇪🇺 EMA · Wed 18 Nov 2026
EU Health Security Committee urges stronger action on carbapenem-resistant bacteria as infections rise
🇪🇺 European Commission (DG SANTE) · Wed 18 Nov 2026
AIFA starts rolling review of daraxonrasib after positive CHMP opinion in pancreatic cancer
🇮🇹 AIFA · Wed 18 Nov 2026
Portugal's antibiotic use stays below EU average, but broad-spectrum prescribing remains a concern
🇵🇹 INFARMED · Wed 18 Nov 2026
CMS publishes Performance Year 2025 results for Medicare Shared Savings Program ACOs
🇺🇸 CMS · Tue 17 Nov 2026